Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: A randomized clinical trial

JAMA

Volumn 309, Issue 20, 2013, Pages 2111-2120

  Schmidt, Barbara ^a,b   Whyte, Robin K ^c   Asztalos, Elizabeth V ^d   Moddemann, Diane ^e   Poets, Christian ^f   Rabi, Yacov ^g   Solimano, Alfonso ^h   Roberts, Robin S ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g UNIVERSITY OF CALGARY   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ARGENTINA; ARTERIAL OXYGEN SATURATION; ARTICLE; BLINDNESS; BRAIN INJURY; CANADA; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FINLAND; FOLLOW UP; GERMANY; HEARING IMPAIRMENT; HUMAN; INFANT; INFANT MORTALITY; ISRAEL; LANGUAGE DELAY; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTICENTER STUDY; NEWBORN; OXYGEN THERAPY; PARALLEL DESIGN; PREMATURITY; PRIORITY JOURNAL; PULSE OXIMETER; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL; RETROLENTAL FIBROPLASIA; UNITED STATES;

EID: 84877954367     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.5555     Document Type: Article

References (33)

1. Tin W. Oxygen therapy: 50 years of uncertainty. Pediatrics. 2002;110(3):615-616. (Pubitemid 34976692)
2. Silverman WA. A cautionary tale about supplemental oxygen: the albatross of neonatal medicine. Pediatrics. 2004;113(2):394-396. (Pubitemid 38177093)
3. Higgins RD, Bancalari E,Willinger M, Raju TN. Executive summary of the workshop on oxygen in neonatal therapies: controversies and opportunities for research. Pediatrics. 2007;119(4):790-796. (Pubitemid 46556680)
4. Askie LM, Henderson-Smart DJ, Ko H. Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev. 2009;(1): CD001077. doi:10.1002/14651858. CD001077.pub2.
5. Saugstad OD, Aune D. In search of the optimal oxygen saturation for extremely low birth weight infants: a systematic review and meta-analysis. Neonatology. 2011;100(1):1-8.
6. Weinberger B, Laskin DL, Heck DE, Laskin JD. Oxygen toxicity in premature infants. Toxicol Appl Pharmacol. 2002;181(1):60-67. (Pubitemid 34615412)
7. Saugstad OD. Oxidative stress in the newborn - a 30-year perspective. Biol Neonate. 2005;88(3):228-236. (Pubitemid 41433555)
8. Silverman WA. Retrolental Fibroplasia: A Modern Parable. New York, NY: Grune & Stratton; 1980.
9. Whyte RK. First day neonatal mortality since 1935: re-examination of the Cross hypothesis. BMJ. 1992; 304(6823):343-346.
10. Cole CH, Wright KW, Tarnow-Mordi W, Phelps DL; Pulse Oximetry Saturation Trial for Prevention of Retinopathy of Prematurity Planning Study Group. Resolving our uncertainty about oxygen therapy. Pediatrics. 2003;112(6 Pt 1):1415-1419. (Pubitemid 37523428)
11. Tin W,Milligan DW, Pennefather P, Hey E. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed. 2001;84(2):F106-F110. (Pubitemid 32250852)
12. Askie LM, Brocklehurst P, Darlow BA, Finer N, Schmidt B, Tarnow-Mordi W; NeOProM Collaborative Group. NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC Pediatr. 2011;11:6.
13. Carlo WA, Finer NN, Walsh MC, et al SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med. 2010;362(21):1959-1969.
14. Vaucher YE, Peralta-Carcelen M, Finer NN, et al SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med. 2012;367(26):2495-2504.
15. Stenson B, Brocklehurst P, Tarnow-Mordi W; U.K. BOOST II trial; Australian BOOST II trial; New Zealand BOOST II trial. Increased 36-week survival with high oxygen saturation target in extremely preterm infants. N Engl J Med. 2011;364(17):1680-1682.
16. Ahmed SJ, Rich W, Finer NN. The effect of averaging time on oximetry values in the premature infant. Pediatrics. 2010;125(1):e115-e121.
17. Vagedes J, Poets CF, Dietz K. Averaging time, desaturation level, duration and extent. Arch Dis Child Fetal Neonatal Ed. 2013;98(3):F265-F266.
18. Johnston ED, Boyle B, Juszczak E, King A, Brocklehurst P, Stenson BJ. Oxygen targeting in preterm infants using the Masimo SET Radical pulse oximeter. Arch Dis Child Fetal Neonatal Ed. 2011; 96(6):F429-F433.
19. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med . 2001;163(7):1723-1729. (Pubitemid 32578778)
20. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39(4):214-223. (Pubitemid 27226331)
21. Bayley N. Manual for the Bayley Scales of Infant and Toddler Development. 3rd ed. San Antonio, TX: Psychological Corp; 2006.
22. Anderson PJ, De Luca CR, Hutchinson E, Roberts G, Doyle LW; Victorian Infant Collaborative Group. Underestimation of developmental delay by the new Bayley-III Scale. Arch Pediatr Adolesc Med. 2010;164(4):352-356.
23. Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2006;117(2):572-576.
24. A SAS Program for the CDC Growth Charts. http://www.cdc.gov/nccdphp/ dnpao/growthcharts/resources/sas.htm. Accessed September 12, 2010.
25. Kramer MS, Platt RW, Wen SW, et al; Fetal/ Infant Health Study Group of the Canadian Perinatal Surveillance System. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics. 2001;108(2):E35.
26. Bassler D, Briel M, Montori VM, et al; STOPIT-2 Study Group. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA. 2010;303(12):1180-1187.
27. Rich W, Finer NN, Gantz MG, et al SUPPORT and Generic Database Subcommittees of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Enrollment of extremely low birth weight infants in a clinical research study may not be representative. Pediatrics. 2012;129(3):480-484.
28. Brocklehurst P. Boost-II UK: benefits of oxygen saturation targeting: protocol - which oxygen saturation level should we use for very premature infants? a randomised controlled trial. Version 3. University of Oxford; 2011. https://www.npeu.ox.ac.uk/files/downloads/boost/BOOSTII-Protocol-Version-3-Nov- 1.pdf. Accessed December 29, 2012.
29. Armbruster J, Schmidt B, Poets CF, Bassler D. Nurses' compliance with alarm limits for pulse oximetry: qualitative study. J Perinatol. 2010;30(8): 531-534.
30. Greenspan JS, Goldsmith JP. Oxygen therapy in preterm infants: hitting the target. Pediatrics. 2006;118(4):1740-1741. (Pubitemid 46393832)
31. Hagadorn JI, Furey AM, Nghiem TH, et al AVIOx Study Group. Achieved versus intended pulse oximeter saturation in infants born less than 28 weeks' gestation: the AVIOx study. Pediatrics. 2006;118(4):1574-1582. (Pubitemid 46393804)
32. Deans KJ, Minneci PC, Eichacker PQ, Natanson C. Defining the standard of care in randomized controlled trials of titrated therapies. Curr Opin Crit Care. 2004;10(6):579-582. (Pubitemid 39620213)
33. Msall ME, Phelps DL, Hardy RJ, et al Cryotherapy for Retinopathy of Prematurity Cooperative Group. Educational and social competencies at 8 years in children with threshold retinopathy of prematurity in the CRYO-ROP multicenter study. Pediatrics. 2004;113(4):790-799. (Pubitemid 38437385)